{
    "eid": "2-s2.0-85092472405",
    "title": "Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma",
    "cover-date": "2020-10-09",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry",
            "@code": "1303",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Cell Biology",
            "@code": "1307",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Cholangiocarcinoma",
        "Invasion",
        "Necroptosis",
        "Receptor-interacting protein kinase 1 (RIPK1)",
        "Smac mimetic",
        "Toll-like receptor 3"
    ],
    "authors": [
        "Thanpisit Lomphithak",
        "Swati Choksi",
        "Apiwat Mutirangura",
        "Rutaiwan Tohtong",
        "Tewin Tencomnao",
        "Hajime Usubuchi",
        "Michiaki Unno",
        "Hironobu Sasano",
        "Siriporn Jitkaew"
    ],
    "citedby-count": 4,
    "ref-count": 88,
    "ref-list": [
        "Cholangiocarcinoma 2020: The next horizon in mechanisms and management",
        "Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: A comparative multicentre study in Japan",
        "Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer",
        "Molecular Bases of Chemoresistance in Cholangiocarcinoma",
        "Cholangiocarcinoma - Evolving concepts and therapeutic strategies",
        "Cholangiocarcinoma: Current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)",
        "Chronic Inflammation and Cytokines in the Tumor Microenvironment",
        "Prospects for combining targeted and conventional cancer therapy with immunotherapy",
        "Toll-like receptors in systemic autoimmune disease",
        "MRNA is an endogenous ligand for Toll-like receptor 3",
        "Exploiting poly(I:C) to induce cancer cell apoptosis",
        "Toll-Like Receptor Signaling Pathways",
        "Phase I-II trials of poly IC stabilized with poly-L-lysine",
        "Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients",
        "Therapeutic in Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial",
        "Induction of CD8+T-Cell Responses against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations with \u03b1-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients with Recurrent Malignant Glioma",
        "TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer",
        "TLR3 can directly trigger apoptosis in human cancer cells",
        "Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?",
        "Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells",
        "Identification of Toll-Like Receptor 3 as a Potential Therapeutic Target in Clear Cell Renal Cell Carcinoma",
        "Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-a-dependent mechanism",
        "TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo",
        "Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: Consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic",
        "Recurrent Overexpression of c-IAP2 in EBV-Associated Nasopharyngeal Carcinomas: Critical Role in Resistance to Toll-like Receptor 3-Mediated Apoptosis 1,2",
        "TLR3 Ligand Induces NF- B Activation and Various Fates of Multiple Myeloma Cells Depending on IFN- Production",
        "Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway",
        "Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas",
        "Defective NF- B Signaling in Metastatic Head and Neck Cancer Cells Leads to Enhanced Apoptosis by Double-Stranded RNA",
        "Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells",
        "MDA5 complements TLR3 in suppression of neuroblastoma",
        "Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis",
        "DsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8",
        "TLR3 expression induces apoptosis in human non-small-cell lung cancer",
        "Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma",
        "CIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms",
        "Death receptor signal transducers: Nodes of coordination in immune signaling networks",
        "Regulated necrosis: The expanding network of non-apoptotic cell death pathways",
        "Hallmarks of Cancer: The Next Generation",
        "Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes",
        "Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity",
        "Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity",
        "RIPK1 and NF- B signaling in dying cells determines cross-priming of CD8+ T cells",
        "RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1&x3B1; Release, and efficient paracrine dendritic cell activation",
        "PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs up Immune Effector-Mediated Tumor Elimination in Vivo",
        "Targeting IAP proteins for therapeutic intervention in cancer",
        "IAPs: From caspase inhibitors to modulators of NF-\u03baB, inflammation and cancer",
        "Smac mimetics and innate immune stimuli synergize to promote tumor death",
        "RIPK1 and RIPK3: Critical regulators of inflammation and cell death",
        "RIP1 is an essential mediator of Toll-like receptor 3-induced NF-\u03baB activation",
        "Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death",
        "Expression of the RIP-1 Gene and its Role in Growth and Invasion of Human Gallbladder Carcinoma",
        "Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinoma",
        "Toll-like receptor stimulation in cancer: A pro- And anti-tumor double-edged sword",
        "Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient",
        "Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method",
        "Genome engineering using the CRISPR-Cas9 system",
        "The cytoplasmic nuclear receptor RAR\u03b3controls RIP1 initiated cell death when cIAP activity is inhibited",
        "Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: Critical role in resistance to Toll-like receptor 3-mediated apoptosis",
        "Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells",
        "Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis",
        "A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells",
        "Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells",
        "Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains",
        "TLR3 can directly trigger apoptosis in human cancer cells",
        "Toll-like receptor 3 expression inhibits cell invasion and migration and predicts a favorable prognosis in neuroblastoma",
        "TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis",
        "TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer",
        "Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients",
        "Immunotherapeutic effects of intratumoral nanoplexed poly I:C",
        "Promises and Challenges of Smac Mimetics as Cancer Therapeutics",
        "Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics",
        "Absence of RIPK3 predicts necroptosis resistance in malignant melanoma",
        "Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-\u03b1 and chemotherapeutic gemcitabine-induced necroptosis",
        "Autophagy facilitates TLR4- And TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination",
        "Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors",
        "Toll-like receptor 3-mediated tumor invasion in head and neck cancer",
        "Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer",
        "RIP1 activates PI3K-Akt via a dual mechanism involving NF-\u03baB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN",
        "Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-B: Implication in breast cancer metastasis",
        "RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC",
        "Receptor-interacting protein kinase 1 promotes cholangiocarcinoma proliferation and lymphangiogenesis through the activation protein 1 pathway",
        "RIP1 Kinase Is an Oncogenic Driver in Melanoma",
        "RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer",
        "C-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor \u03b1 (TNF\u03b1)-induced NF-\u03baB Activation",
        "CIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sendai",
            "@id": "60016416",
            "affilname": "Tohoku University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016416",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bethesda",
            "@id": "60013409",
            "affilname": "National Cancer Institute (NCI)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013409",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ratchadaphiseksomphot Endowment Fund",
        "Newton Fund",
        "Office of the Higher Education Commission",
        "Medical Research Council",
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}